APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Drug Repurposing Platform

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI Drug Repurposing Platform Market Analysis and Forecast 2026-2032

12 August 2026178 pages

Choose your research edition.

Industry ResearchAI Drug Repurposing Platform Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Drug Repurposing Platform Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal AI Drug Repurposing Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Drug Repurposing Platform Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Drug Repurposing Platform Market Analysis and Forecast 2026-2032178 pages · $4,950 USD

Market perspective

The global AI Drug Repurposing Platform market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI Drug Repurposing Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI Drug Repurposing Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI Drug Repurposing Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI Drug Repurposing Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI Drug Repurposing Platform include Recursion, Lantern Pharma, SOM Biotech, Standigm, Pharos iBio, Aitia, Causaly, BenevolentAI and Healx, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI Drug Repurposing Platform, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI Drug Repurposing Platform, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Drug Repurposing Platform, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI Drug Repurposing Platform revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI Drug Repurposing Platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI Drug Repurposing Platform revenue, projected growth trends, production technology, application and end-user industry.

AI Drug Repurposing Platform Segment by Company

Recursion

Lantern Pharma

SOM Biotech

Standigm

Pharos iBio

Aitia

Causaly

BenevolentAI

Healx

Insilico Medicine

AI Drug Repurposing Platform Segment by Type

Target and Mechanism Mining

Drug–Disease Matching

Indication Expansion

Combination Therapy Prediction

Evidence Ranking and Validation

Safety and Translational Assessment

AI Drug Repurposing Platform Segment by Application

Rare Disease Repurposing

Oncology Indication Expansion

Infectious Disease Response

CNS and Neurology Research

Immunology and Inflammation Research

Asset Rescue and Pipeline Optimization

AI Drug Repurposing Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Repurposing Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Drug Repurposing Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Repurposing Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI Drug Repurposing Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI Drug Repurposing Platform company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Drug Repurposing Platform revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Drug Repurposing Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Target and Mechanism Mining Major Player Table 3. Drug–Disease Matching Major Player Table 4. Indication Expansion Major Player Table 5. Combination Therapy Prediction Major Player Table 6. Evidence Ranking and Validation Major Player Table 7. Safety and Translational Assessment Major Player Table 8. Global AI Drug Repurposing Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Rare Disease Repurposing Major Player Table 10. Oncology Indication Expansion Major Player Table 11. Infectious Disease Response Major Player Table 12. CNS and Neurology Research Major Player Table 13. Immunology and Inflammation Research Major Player Table 14. Asset Rescue and Pipeline Optimization Major Player Table 15. AI Drug Repurposing Platform Industry Trends Table 16. AI Drug Repurposing Platform Industry Drivers Table 17. AI Drug Repurposing Platform Industry Opportunities and Challenges Table 18. AI Drug Repurposing Platform Industry Restraints Table 19. Global AI Drug Repurposing Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 20. Global AI Drug Repurposing Platform Market Size by Region (2021-2026) & (US$ Million) Table 21. Global AI Drug Repurposing Platform Market Share by Region (2021-2026) Table 22. Global AI Drug Repurposing Platform Market Size by Region (2027-2032) & (US$ Million) Table 23. Global AI Drug Repurposing Platform Market Share by Region (2027-2032) Table 24. Global AI Drug Repurposing Platform Revenue by Players (US$ Million) & (2021-2026) Table 25. Global AI Drug Repurposing Platform Revenue Market Share by Players (2021-2026) Table 26. Global AI Drug Repurposing Platform Key Players Ranking, 2024 VS 2025 VS 2026 Table 27. Global AI Drug Repurposing Platform Key Players Headquarters & Area Served Table 28. Global AI Drug Repurposing Platform Players, Product Type & Application Table 29. Global AI Drug Repurposing Platform Players Establishment Date Table 30. Global Players Market Concentration Ratio (CR5 and HHI) Table 31. Global AI Drug Repurposing Platform by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global AI Drug Repurposing Platform Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global AI Drug Repurposing Platform Revenue by Type (2021-2026) & (US$ Million) Table 34. Global AI Drug Repurposing Platform Revenue by Type (2027-2032) & (US$ Million) Table 35. Global AI Drug Repurposing Platform Revenue Market Share by Type (2021-2026) Table 36. Global AI Drug Repurposing Platform Revenue Market Share by Type (2027-2032) Table 37. Global AI Drug Repurposing Platform Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global AI Drug Repurposing Platform Revenue by Application (2021-2026) & (US$ Million) Table 39. Global AI Drug Repurposing Platform Revenue by Application (2027-2032) & (US$ Million) Table 40. Global AI Drug Repurposing Platform Revenue Market Share by Application (2021-2026) Table 41. Global AI Drug Repurposing Platform Revenue Market Share by Application (2027-2032) Table 42. Recursion Company Information Table 43. Recursion Business Overview Table 44. Recursion AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Recursion AI Drug Repurposing Platform Product Portfolio Table 46. Recursion Recent Development Table 47. Lantern Pharma Company Information Table 48. Lantern Pharma Business Overview Table 49. Lantern Pharma AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Lantern Pharma AI Drug Repurposing Platform Product Portfolio Table 51. Lantern Pharma Recent Development Table 52. SOM Biotech Company Information Table 53. SOM Biotech Business Overview Table 54. SOM Biotech AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. SOM Biotech AI Drug Repurposing Platform Product Portfolio Table 56. SOM Biotech Recent Development Table 57. Standigm Company Information Table 58. Standigm Business Overview Table 59. Standigm AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Standigm AI Drug Repurposing Platform Product Portfolio Table 61. Standigm Recent Development Table 62. Pharos iBio Company Information Table 63. Pharos iBio Business Overview Table 64. Pharos iBio AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Pharos iBio AI Drug Repurposing Platform Product Portfolio Table 66. Pharos iBio Recent Development Table 67. Aitia Company Information Table 68. Aitia Business Overview Table 69. Aitia AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Aitia AI Drug Repurposing Platform Product Portfolio Table 71. Aitia Recent Development Table 72. Causaly Company Information Table 73. Causaly Business Overview Table 74. Causaly AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Causaly AI Drug Repurposing Platform Product Portfolio Table 76. Causaly Recent Development Table 77. BenevolentAI Company Information Table 78. BenevolentAI Business Overview Table 79. BenevolentAI AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. BenevolentAI AI Drug Repurposing Platform Product Portfolio Table 81. BenevolentAI Recent Development Table 82. Healx Company Information Table 83. Healx Business Overview Table 84. Healx AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Healx AI Drug Repurposing Platform Product Portfolio Table 86. Healx Recent Development Table 87. Insilico Medicine Company Information Table 88. Insilico Medicine Business Overview Table 89. Insilico Medicine AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Insilico Medicine AI Drug Repurposing Platform Product Portfolio Table 91. Insilico Medicine Recent Development Table 92. North America AI Drug Repurposing Platform Revenue by Type (2021-2026) & (US$ Million) Table 93. North America AI Drug Repurposing Platform Revenue by Type (2027-2032) & (US$ Million) Table 94. North America AI Drug Repurposing Platform Revenue by Application (2021-2026) & (US$ Million) Table 95. North America AI Drug Repurposing Platform Revenue by Application (2027-2032) & (US$ Million) Table 96. North America AI Drug Repurposing Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. North America AI Drug Repurposing Platform Revenue by Country (2021-2026) & (US$ Million) Table 98. North America AI Drug Repurposing Platform Revenue by Country (US$ Million) & (2027-2032) Table 99. Europe AI Drug Repurposing Platform Revenue by Type (2021-2026) & (US$ Million) Table 100. Europe AI Drug Repurposing Platform Revenue by Type (2027-2032) & (US$ Million) Table 101. Europe AI Drug Repurposing Platform Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe AI Drug Repurposing Platform Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe AI Drug Repurposing Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe AI Drug Repurposing Platform Revenue by Country (2021-2026) & (US$ Million) Table 105. Europe AI Drug Repurposing Platform Revenue by Country (US$ Million) & (2027-2032) Table 106. China AI Drug Repurposing Platform Revenue by Type (2021-2026) & (US$ Million) Table 107. China AI Drug Repurposing Platform Revenue by Type (2027-2032) & (US$ Million) Table 108. China AI Drug Repurposing Platform Revenue by Application (2021-2026) & (US$ Million) Table 109. China AI Drug Repurposing Platform Revenue by Application (2027-2032) & (US$ Million) Table 110. Asia AI Drug Repurposing Platform Revenue by Type (2021-2026) & (US$ Million) Table 111. Asia AI Drug Repurposing Platform Revenue by Type (2027-2032) & (US$ Million) Table 112. Asia AI Drug Repurposing Platform Revenue by Application (2021-2026) & (US$ Million) Table 113. Asia AI Drug Repurposing Platform Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia AI Drug Repurposing Platform Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Asia AI Drug Repurposing Platform Revenue by Region (US$ Million) & (2021-2026) Table 116. Asia AI Drug Repurposing Platform Revenue by Region (US$ Million) & (2027-2032) Table 117. SAMEA AI Drug Repurposing Platform Revenue by Type (2021-2026) & (US$ Million) Table 118. SAMEA AI Drug Repurposing Platform Revenue by Type (2027-2032) & (US$ Million) Table 119. SAMEA AI Drug Repurposing Platform Revenue by Application (2021-2026) & (US$ Million) Table 120. SAMEA AI Drug Repurposing Platform Revenue by Application (2027-2032) & (US$ Million) Table 121. SAMEA AI Drug Repurposing Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. SAMEA AI Drug Repurposing Platform Revenue by Country (2021-2026) & (US$ Million) Table 123. SAMEA AI Drug Repurposing Platform Revenue by Country (US$ Million) & (2027-2032) Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. AI Drug Repurposing Platform Image Figure 2. Global AI Drug Repurposing Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Drug Repurposing Platform Market Size Share 2021 VS 2025 VS 2032 Figure 4. Target and Mechanism Mining Image Figure 5. Drug–Disease Matching Image Figure 6. Indication Expansion Image Figure 7. Combination Therapy Prediction Image Figure 8. Evidence Ranking and Validation Image Figure 9. Safety and Translational Assessment Image Figure 10. Global AI Drug Repurposing Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global AI Drug Repurposing Platform Market Size Share 2021 VS 2025 VS 2032 Figure 12. Rare Disease Repurposing Image Figure 13. Oncology Indication Expansion Image Figure 14. Infectious Disease Response Image Figure 15. CNS and Neurology Research Image Figure 16. Immunology and Inflammation Research Image Figure 17. Asset Rescue and Pipeline Optimization Image Figure 18. Global AI Drug Repurposing Platform Market Size (US$ Million) & (2021-2032) Figure 19. Global AI Drug Repurposing Platform Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 20. Global AI Drug Repurposing Platform Market Share by Region: 2021 VS 2025 VS 2032 Figure 21. Global AI Drug Repurposing Platform Players Revenue Share Top 10 and Top 5 in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global AI Drug Repurposing Platform Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global AI Drug Repurposing Platform Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global AI Drug Repurposing Platform Revenue Market Share by Type (2021-2032) Figure 26. Global AI Drug Repurposing Platform Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global AI Drug Repurposing Platform Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 28. Global AI Drug Repurposing Platform Revenue Market Share by Application (2021-2032) Figure 29. North America AI Drug Repurposing Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. North America AI Drug Repurposing Platform Revenue Share by Type (2021-2032) Figure 31. North America AI Drug Repurposing Platform Revenue Share by Application (2021-2032) Figure 32. North America AI Drug Repurposing Platform Revenue Share by Country (2021-2032) Figure 33. United States AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Canada AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Mexico AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Europe AI Drug Repurposing Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 37. Europe AI Drug Repurposing Platform Revenue Share by Type (2021-2032) Figure 38. Europe AI Drug Repurposing Platform Revenue Share by Application (2021-2032) Figure 39. Europe AI Drug Repurposing Platform Revenue Share by Country (2021-2032) Figure 40. Germany AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. France AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. U.K. AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Italy AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Spain AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Russia AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Netherlands AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. Nordic Countries AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. China AI Drug Repurposing Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. China AI Drug Repurposing Platform Revenue Share by Type (2021-2032) Figure 50. China AI Drug Repurposing Platform Revenue Share by Application (2021-2032) Figure 51. Asia AI Drug Repurposing Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 52. Asia AI Drug Repurposing Platform Revenue Share by Type (2021-2032) Figure 53. Asia AI Drug Repurposing Platform Revenue Share by Application (2021-2032) Figure 54. Asia AI Drug Repurposing Platform Revenue Share by Region (2021-2032) Figure 55. Japan AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. South Korea AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. India AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Australia AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Taiwan AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Southeast Asia AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. SAMEA AI Drug Repurposing Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 62. SAMEA AI Drug Repurposing Platform Revenue Share by Type (2021-2032) Figure 63. SAMEA AI Drug Repurposing Platform Revenue Share by Application (2021-2032) Figure 64. SAMEA AI Drug Repurposing Platform Revenue Share by Country (2021-2032) Figure 65. Brazil AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Argentina AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Chile AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Colombia AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Peru AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Saudi Arabia AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Israel AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. UAE AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Turkey AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Iran AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Egypt AI Drug Repurposing Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Target and Mechanism Mining
  • Drug–Disease Matching
  • Indication Expansion
  • Combination Therapy Prediction
  • Evidence Ranking and Validation
  • Safety and Translational Assessment
Applications
  • Rare Disease Repurposing
  • Oncology Indication Expansion
  • Infectious Disease Response
  • CNS and Neurology Research
  • Immunology and Inflammation Research
  • Asset Rescue and Pipeline Optimization
Companies covered
  • Recursion
  • Lantern Pharma
  • SOM Biotech
  • Standigm
  • Pharos iBio
  • Aitia
  • Causaly
  • BenevolentAI
  • Healx
  • Insilico Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI Drug Repurposing Platform Market by Type
  3. 1.2.1 Global AI Drug Repurposing Platform Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Target and Mechanism Mining
  5. 1.2.3 Drug–Disease Matching
  6. 1.2.4 Indication Expansion
  7. 1.2.5 Combination Therapy Prediction
  8. 1.2.6 Evidence Ranking and Validation
  9. 1.2.7 Safety and Translational Assessment
  10. 1.3 AI Drug Repurposing Platform Market by Application
  11. 1.3.1 Global AI Drug Repurposing Platform Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Rare Disease Repurposing
  13. 1.3.3 Oncology Indication Expansion
  14. 1.3.4 Infectious Disease Response
  15. 1.3.5 CNS and Neurology Research
  16. 1.3.6 Immunology and Inflammation Research
  17. 1.3.7 Asset Rescue and Pipeline Optimization
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 AI Drug Repurposing Platform Market Dynamics
  1. 2.1 AI Drug Repurposing Platform Industry Trends
  2. 2.2 AI Drug Repurposing Platform Industry Drivers
  3. 2.3 AI Drug Repurposing Platform Industry Opportunities and Challenges
  4. 2.4 AI Drug Repurposing Platform Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI Drug Repurposing Platform Market Perspective (2021-2032)
  2. 3.2 Global AI Drug Repurposing Platform Growth Trends by Region
  3. 3.2.1 Global AI Drug Repurposing Platform Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI Drug Repurposing Platform Market Size by Region (2021-2026)
  5. 3.2.3 Global AI Drug Repurposing Platform Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI Drug Repurposing Platform Revenue by Players
  2. 4.1.1 Global AI Drug Repurposing Platform Revenue by Players (2021-2026)
  3. 4.1.2 Global AI Drug Repurposing Platform Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI Drug Repurposing Platform Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI Drug Repurposing Platform Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI Drug Repurposing Platform Key Players Headquarters & Area Served
  7. 4.4 Global AI Drug Repurposing Platform Players, Product Type & Application
  8. 4.5 Global AI Drug Repurposing Platform Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI Drug Repurposing Platform Market CR5 and HHI
  11. 4.6.3 2025 AI Drug Repurposing Platform Tier 1, Tier 2, and Tier 3
5 AI Drug Repurposing Platform Market Size by Type
  1. 5.1 Global AI Drug Repurposing Platform Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Drug Repurposing Platform Revenue by Type (2021-2032)
  3. 5.3 Global AI Drug Repurposing Platform Revenue Market Share by Type (2021-2032)
6 AI Drug Repurposing Platform Market Size by Application
  1. 6.1 Global AI Drug Repurposing Platform Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI Drug Repurposing Platform Revenue by Application (2021-2032)
  3. 6.3 Global AI Drug Repurposing Platform Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Recursion
  2. 7.1.1 Recursion Company Information
  3. 7.1.2 Recursion Business Overview
  4. 7.1.3 Recursion AI Drug Repurposing Platform Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Recursion AI Drug Repurposing Platform Product Portfolio
  6. 7.1.5 Recursion Recent Developments
  7. 7.2 Lantern Pharma
  8. 7.2.1 Lantern Pharma Company Information
  9. 7.2.2 Lantern Pharma Business Overview
  10. 7.2.3 Lantern Pharma AI Drug Repurposing Platform Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Lantern Pharma AI Drug Repurposing Platform Product Portfolio
  12. 7.2.5 Lantern Pharma Recent Developments
  13. 7.3 SOM Biotech
  14. 7.3.1 SOM Biotech Company Information
  15. 7.3.2 SOM Biotech Business Overview
  16. 7.3.3 SOM Biotech AI Drug Repurposing Platform Revenue and Gross Margin (2021-2026)
  17. 7.3.4 SOM Biotech AI Drug Repurposing Platform Product Portfolio
  18. 7.3.5 SOM Biotech Recent Developments
  19. 7.4 Standigm
  20. 7.4.1 Standigm Company Information
  21. 7.4.2 Standigm Business Overview
  22. 7.4.3 Standigm AI Drug Repurposing Platform Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Standigm AI Drug Repurposing Platform Product Portfolio
  24. 7.4.5 Standigm Recent Developments
  25. 7.5 Pharos iBio
  26. 7.5.1 Pharos iBio Company Information
  27. 7.5.2 Pharos iBio Business Overview
  28. 7.5.3 Pharos iBio AI Drug Repurposing Platform Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Pharos iBio AI Drug Repurposing Platform Product Portfolio
  30. 7.5.5 Pharos iBio Recent Developments
  31. 7.6 Aitia
  32. 7.6.1 Aitia Company Information
  33. 7.6.2 Aitia Business Overview
  34. 7.6.3 Aitia AI Drug Repurposing Platform Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Aitia AI Drug Repurposing Platform Product Portfolio
  36. 7.6.5 Aitia Recent Developments
  37. 7.7 Causaly
  38. 7.7.1 Causaly Company Information
  39. 7.7.2 Causaly Business Overview
  40. 7.7.3 Causaly AI Drug Repurposing Platform Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Causaly AI Drug Repurposing Platform Product Portfolio
  42. 7.7.5 Causaly Recent Developments
  43. 7.8 BenevolentAI
  44. 7.8.1 BenevolentAI Company Information
  45. 7.8.2 BenevolentAI Business Overview
  46. 7.8.3 BenevolentAI AI Drug Repurposing Platform Revenue and Gross Margin (2021-2026)
  47. 7.8.4 BenevolentAI AI Drug Repurposing Platform Product Portfolio
  48. 7.8.5 BenevolentAI Recent Developments
  49. 7.9 Healx
  50. 7.9.1 Healx Company Information
  51. 7.9.2 Healx Business Overview
  52. 7.9.3 Healx AI Drug Repurposing Platform Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Healx AI Drug Repurposing Platform Product Portfolio
  54. 7.9.5 Healx Recent Developments
  55. 7.10 Insilico Medicine
  56. 7.10.1 Insilico Medicine Company Information
  57. 7.10.2 Insilico Medicine Business Overview
  58. 7.10.3 Insilico Medicine AI Drug Repurposing Platform Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Insilico Medicine AI Drug Repurposing Platform Product Portfolio
  60. 7.10.5 Insilico Medicine Recent Developments
8 North America
  1. 8.1 North America AI Drug Repurposing Platform Revenue (2021-2032)
  2. 8.2 North America AI Drug Repurposing Platform Revenue by Type (2021-2032)
  3. 8.2.1 North America AI Drug Repurposing Platform Revenue by Type (2021-2026)
  4. 8.2.2 North America AI Drug Repurposing Platform Revenue by Type (2027-2032)
  5. 8.3 North America AI Drug Repurposing Platform Revenue Share by Type (2021-2032)
  6. 8.4 North America AI Drug Repurposing Platform Revenue by Application (2021-2032)
  7. 8.4.1 North America AI Drug Repurposing Platform Revenue by Application (2021-2026)
  8. 8.4.2 North America AI Drug Repurposing Platform Revenue by Application (2027-2032)
  9. 8.5 North America AI Drug Repurposing Platform Revenue Share by Application (2021-2032)
  10. 8.6 North America AI Drug Repurposing Platform Revenue by Country
  11. 8.6.1 North America AI Drug Repurposing Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI Drug Repurposing Platform Revenue by Country (2021-2026)
  13. 8.6.3 North America AI Drug Repurposing Platform Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI Drug Repurposing Platform Revenue (2021-2032)
  2. 9.2 Europe AI Drug Repurposing Platform Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI Drug Repurposing Platform Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI Drug Repurposing Platform Revenue by Type (2027-2032)
  5. 9.3 Europe AI Drug Repurposing Platform Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI Drug Repurposing Platform Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI Drug Repurposing Platform Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI Drug Repurposing Platform Revenue by Application (2027-2032)
  9. 9.5 Europe AI Drug Repurposing Platform Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI Drug Repurposing Platform Revenue by Country
  11. 9.6.1 Europe AI Drug Repurposing Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI Drug Repurposing Platform Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI Drug Repurposing Platform Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI Drug Repurposing Platform Revenue (2021-2032)
  2. 10.2 China AI Drug Repurposing Platform Revenue by Type (2021-2032)
  3. 10.2.1 China AI Drug Repurposing Platform Revenue by Type (2021-2026)
  4. 10.2.2 China AI Drug Repurposing Platform Revenue by Type (2027-2032)
  5. 10.3 China AI Drug Repurposing Platform Revenue Share by Type (2021-2032)
  6. 10.4 China AI Drug Repurposing Platform Revenue by Application (2021-2032)
  7. 10.4.1 China AI Drug Repurposing Platform Revenue by Application (2021-2026)
  8. 10.4.2 China AI Drug Repurposing Platform Revenue by Application (2027-2032)
  9. 10.5 China AI Drug Repurposing Platform Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI Drug Repurposing Platform Revenue (2021-2032)
  2. 11.2 Asia AI Drug Repurposing Platform Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI Drug Repurposing Platform Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI Drug Repurposing Platform Revenue by Type (2027-2032)
  5. 11.3 Asia AI Drug Repurposing Platform Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI Drug Repurposing Platform Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI Drug Repurposing Platform Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI Drug Repurposing Platform Revenue by Application (2027-2032)
  9. 11.5 Asia AI Drug Repurposing Platform Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI Drug Repurposing Platform Revenue by Country
  11. 11.6.1 Asia AI Drug Repurposing Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI Drug Repurposing Platform Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI Drug Repurposing Platform Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI Drug Repurposing Platform Revenue (2021-2032)
  2. 12.2 SAMEA AI Drug Repurposing Platform Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI Drug Repurposing Platform Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI Drug Repurposing Platform Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI Drug Repurposing Platform Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI Drug Repurposing Platform Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI Drug Repurposing Platform Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI Drug Repurposing Platform Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI Drug Repurposing Platform Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI Drug Repurposing Platform Revenue by Country
  11. 12.6.1 SAMEA AI Drug Repurposing Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI Drug Repurposing Platform Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI Drug Repurposing Platform Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst